Our Organ Modelling Congress addresses an important and expanding field which provides new understandings in organ functionality and novel approaches to drug
development. These engineered human organs using Organ-on-a-Chip, Tissue-on-a-Chip & Organoids are a remarkable tool

The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

Integrating a One Health approach in the decision-making process is key for anticipating and tackling crises linked to emerging and reemerging pathogens that affect humans, animals or both

The Mission aims to connect the Swedish AMR ecosystem to the international AMR ecosystem and vice versa.

At the AFSSI webinar on May 25, 2021 at 3 p.m., Patricia Martin, CSO, will present Vibiosphen's innovative solutions.

Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater ...

The AMR Innovation Mission UK 2021 aims to add to the global curbing of Antimicrobial resistance (AMR) ...